Pharmaceutical Executive

Pharmaceutical Executive Podcast
  • 4.9(15개의 평가)
  • 생명 과학
  • 매일 업데이트

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

  1. Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO

    21시간 전

    Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO

    In today’s Pharmaceutical Executive Daily, Sanofi formally confirms its CEO leadership following a shareholder vote, US prescription drug spending is projected to surpass $1 trillion in 2026, and Inizio launches a next-generation hub services model aimed at simplifying patient access and support.

    3분
  2. Pharmaceutical Executive Daily: Rocket Pharmaceuticals Sells Pediatric Disease Priority Review Voucher

    1일 전

    Pharmaceutical Executive Daily: Rocket Pharmaceuticals Sells Pediatric Disease Priority Review Voucher

    In today's Pharmaceutical Executive Daily, Rocket Pharmaceuticals announces a $180 million sale of its rare pediatric disease priority review voucher, Teva Pharmaceutical enters a definitive agreement to acquire Emalex Biosciences for up to $900 million, and a feature article examines the pharmaceutical supply chain risks converging around the Strait of Hormuz.

    3분
  3. Pharmaceutical Executive Daily: FDA Approves Breztri

    2일 전

    Pharmaceutical Executive Daily: FDA Approves Breztri

    In today's Pharmaceutical Executive Daily, we cover Sun Pharma and IMG Pharma's respective acquisitions, FDA's approval of AstraZeneca's Breztri, and a new feature examining why Ireland has become one of the pharmaceutical industry's most strategically important global manufacturing hubs.

    3분
  4. Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia

    3일 전

    Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia

    In today's Pharmaceutical Executive Daily, Eli Lilly announces a definitive agreement to acquire Ajax Therapeutics for up to $2.3 billion, adding a first-in-class JAK2 inhibitor for blood cancers to its expanding oncology pipeline, the FDA approves a supplemental application for Johnson and Johnson's Caplyta backed by Phase III data showing a 63% reduction in relapse risk in adults with schizophrenia, and Pharmaceutical Executive speaks with Maher Masoud, CEO of MaxCyte, on moving cell and gene therapies toward commercial scale.

    3분
  5. Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie

    6일 전

    Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie

    In today’s Pharmaceutical Executive Daily, the FDA issues a complete response letter to AbbVie for a biologics license application, Regeneron moves to lower patient costs tied to its newly approved gene therapy, and the FDA approves Otarmeni for OTOF-related hearing loss.

    2분
  6. Pharmaceutical Executive Daily: FDA Expands Approvals for Tzield and Dupixent

    4월 23일

    Pharmaceutical Executive Daily: FDA Expands Approvals for Tzield and Dupixent

    In today’s Pharmaceutical Executive Daily, the FDA expands the use of Tzield to young children to delay the onset of stage 3 type 1 diabetes, Dupixent receives an expanded pediatric indication in chronic spontaneous urticaria, and AbbVie announces a $195 million investment to build a new manufacturing campus in North Carolina.

    2분
  7. The Ron Lanton Report: Where Innovations Happens

    4월 23일

    The Ron Lanton Report: Where Innovations Happens

    In this episode, Ron Lanton examines how geography is becoming a central strategic variable in healthcare, as policy, trade dynamics, and infrastructure increasingly dictate where innovation is developed, manufactured, and commercialized.

    9분
  8. Pharmaceutical Executive Daily: Idvynso Receives FDA Approval

    4월 22일

    Pharmaceutical Executive Daily: Idvynso Receives FDA Approval

    In today’s Pharmaceutical Executive Daily, the FDA approves a new treatment for HIV-1 infection in adults, Amazon One Medical launches a GLP-1 weight management program, and a new report highlights which top-selling drugs are most at risk of supply shortages.

    2분
모두 보기(345개)

평가 및 리뷰

4.9
최고 5점
15개의 평가

소개

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 

정보

  • 제작진
    Pharmaceutical Executive Podcast
  • 방송 연도
    2018년 - 2026년
  • 에피소드
    345
  • 등급
    전체 연령 사용가
  • 웹사이트 보기
    Pharmaceutical Executive

좋아할 만한 다른 항목